Causes of Death on Antiretroviral Therapy: A Post-Mortem Study from South Africa

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Wong, Emily B ^a,b,c   Omar, Tanvier ^d   Setlhako, Gosetsemang J ^a   Osih, Regina ^a   Feldman, Charles ^a   Murdoch, David M ^e   Martinson, Neil A ^f,g   Bangsberg, David R ^h   Venter, W D F ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; STAVUDINE; TENOFOVIR;

ADULT; ARTICLE; BACTERIAL INFECTION; BONE MARROW; CADAVER; CAUSE OF DEATH; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HEART; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KIDNEY; LIVER; LUNG; LYMPH NODE; MALE; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NEEDLE BIOPSY; NEOPLASM; SKIN; SOUTH AFRICA; SPLEEN;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOPSY; BACTERIAL INFECTIONS; BIOPSY, NEEDLE; BONE MARROW; CAUSE OF DEATH; FEMALE; HIV; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KIDNEY; LIVER; LUNG; LYMPH NODES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SKIN; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

EID: 84867613369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047542     Document Type: Article

References (43)

1. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One 3: e1725.
2. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R, (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. Aids 22: 1897-1908.
3. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824.
4. Nojilana B, Groenewald P, Bradshaw D, Reagon G, (2009) Quality of cause of death certification at an academic hospital in Cape Town, South Africa. S Afr Med J 99: 648-652.
5. de Cherif TK, Schoeman JH, Cleary S, Meintjes GA, Rebe K, et al. (2009) Early severe morbidity and resource utilization in South African adults on antiretroviral therapy. BMC Infect Dis 9: 205.
6. Leng K, Lonsdorf A, Hartmann M, (2008) Fatal outcome of nevirapine-associated toxic epidermal necrolysis. Int J STD AIDS 19: 642-643.
7. Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, et al. (2007) Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. J Acquir Immune Defic Syndr 46: 318-322.
8. Castelnuovo B, Manabe YC, Kiragga A, Kamya M, Easterbrook P, et al. (2009) Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. Clin Infect Dis 49: 965-972.
9. Etard JF, Ndiaye I, Thierry-Mieg M, Gueye NF, Gueye PM, et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. Aids 20: 1181-1189.
10. Kyeyune R, den Boon S, Cattamanchi A, Davis JL, Worodria W, et al. (2010) Causes of early mortality in HIV-infected TB suspects in an East African referral hospital. J Acquir Immune Defic Syndr 55: 446-450.
11. Cox JA, Lukande RL, Lucas S, Nelson AM, Van Marck E, et al. (2010) Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev 12: 183-194.
12. Martinson NA, Karstaedt A, Venter WD, Omar T, King P, et al. (2007) Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. Aids 21: 2043-2050.
13. Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, et al. (2002) Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 6: 55-63.
14. Chakraborty R, Pulver A, Pulver LS, Musoke R, Palakudy T, et al. (2002) The post-mortem pathology of HIV-1-infected African children. Ann Trop Paediatr 22: 125-131.
15. Cury PM, Pulido CF, Furtado VM, da Palma FM, (2003) Autopsy findings in AIDS patients from a reference hospital in Brazil: analysis of 92 cases. Pathol Res Pract 199: 811-814.
16. Domoua K, N'Dhatz M, Coulibaly G, Traore F, Konan JB, et al. (1995) [Autopsy findings in 70 AIDS patients who died in a department of pneumology in Ivory Coast: impact of tuberculosis]. Med Trop (Mars) 55: 252-254.
17. Lanjewar DN, (2011) The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of 236 autopsied cases in mumbai, India. Patholog Res Int 2011: 547618.
18. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, et al. (1993) The mortality and pathology of HIV infection in a west African city. Aids 7: 1569-1579.
19. Mohar A, Romo J, Salido F, Jessurun J, Ponce de Leon S, et al. (1992) The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. Aids 6: 467-473.
20. Rana FS, Hawken MP, Mwachari C, Bhatt SM, Abdullah F, et al. (2000) Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 24: 23-29.
21. Soeiro Ade M, Hovnanian AL, Parra ER, Canzian M, Capelozzi VL, (2008) Post-mortem histological pulmonary analysis in patients with HIV/AIDS. Clinics (Sao Paulo) 63: 497-502.
22. Lucas S, (2012) Causes of death in the HAART era. Curr Opin Infect Dis 25: 36-41.
23. Greenberg AE, Lucas S, Tossou O, Coulibaly IM, Coulibaly D, et al. (1995) Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Cote d'Ivoire. Aids 9: 1251-1254.
24. (Accessed: Nov 29, 2011) Health Indicators. http://indicatorshstorgza/healthstats/84/data/geo; http://indicatorshstorgza/healthstats/16/data. Durban, South Africa: Health Systems Trust.
25. Baumgart KW, Cook M, Quin J, Painter D, Gatenby PA, et al. (1994) The limited (needle biopsy) autopsy and the acquired immunodeficiency syndrome. Pathology 26: 141-143.
26. Guerra I, Ortiz E, Portu J, Atares B, Aldamiz-Etxebarria M, et al. (2001) Value of limited necropsy in HIV-positive patients. Pathol Res Pract 197: 165-168.
27. Satyanarayana S, Kalghatgi AT, Malaviya AK, Bhardwaj JR, Muralidhar A, et al. (2003) Needle necropsy in AIDS. Indian J Pathol Microbiol 46: 416-419.
28. Gous N, Scott LE, Wong E, Omar T, Venter WD, et al. (2012) Performance of the Roche LightCycler real-time PCR assay for diagnosing extrapulmonary tuberculosis. J Clin Microbiol 50: 2100-2103.
29. Hanzlick R, (1996) Protocol for writing cause-of-death statements for deaths due to natural causes. Arch Intern Med 156: 25-26.
30. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, et al. (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8: 516-523.
31. Murray J, Sonnenberg P, Nelson G, Bester A, Shearer S, et al. (2007) Cause of death and presence of respiratory disease at autopsy in an HIV-1 seroconversion cohort of southern African gold miners. Aids 21Suppl 6: S97-S104.
32. Severe P, Leger P, Charles M, Noel F, Bonhomme G, et al. (2005) Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 353: 2325-2334.
33. MacPherson P, Moshabela M, Martinson N, Pronyk P, (2009) Mortality and loss to follow-up among HAART initiators in rural South Africa. Trans R Soc Trop Med Hyg 103: 588-593.
34. Karstaedt A (2009) Causes of death in patients on ART in a Soweto Clinic, 2004-2009. Cape Town, South Africa.
35. Gupta A, Nadkarni G, Yang WT, Chandrasekhar A, Gupte N, et al. (2011) Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One 6: e28691.
36. Lawn SD, Lipman MC, Easterbrook PJ, (2008) Immune reconstitution disease associated with mycobacterial infections. Curr Opin HIV AIDS 3: 425-431.
37. Murdoch DM, Venter WD, Feldman C, Van Rie A, (2008) Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. Aids 22: 601-610.
38. Lawn SD, Bekker LG, Myer L, Orrell C, Wood R, (2005) Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. Aids 19: 2050-2052.
39. Lawn SD, Wainwright H, Orrell C, (2009) Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. Aids 23: 143-145.
40. Makadzange AT, Ndhlovu CE, Takarinda K, Reid M, Kurangwa M, et al. (2010) Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. Clin Infect Dis 50: 1532-1538.
41. Huston BM, Malouf NN, Azar HA, (1996) Percutaneous needle autopsy sampling. Mod Pathol 9: 1101-1107.
42. Cohen T, Murray M, Wallengren K, Alvarez GG, Samuel EY, et al. (2010) The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study. PLoS Med 7: e1000296.
43. Meintjes G, Rangaka MX, Maartens G, Rebe K, Morroni C, et al. (2009) Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. Clin Infect Dis 48: 667-676.